EUVIMEDEUVIMED entdecken
Crossref

Sintomatología depresiva en pacientes con trastornos de coagulación durante COVID 19: Análisis sociodemográfico y comparativo

Damaris Francis Estrella Castillo, Hector Armando Rubio Zapata, Armando de Jesús López Estrella, Elma Vega Lizama, Laura Isidro Olán, Marco Ramírez Salomón, Marco Antonio Rueda Ventura

Ciencia y Humanismo en la Salud · 2025

DOI: 10.32776/8aqa7r08 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ciencia y Humanismo en la Salud, 2025. Verfasst von Damaris Francis Estrella Castillo und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, the associations between depressive symptomatology and various sociodemographic and clinical variables in patients with coagulation disorders during the COVID-19 pandemic were examined. A sample of 61 patients with bleeding disorders, including hemophilia A, hemophilia B, and von Willebrand disease, completed the Beck Depression Inventory (BDI) via an electronic form distributed through WhatsApp. The results showed that certain subgroups of the population, such as those who tested positive for COVID-19, were without a partner, were women, were young, and had von Willebrand disease, had higher scores on the BDI. These findings are consistent with previous studies that have demonstrated significant emotional burden in patients with COVID-19, as well as the influence of sociodemographic factors on mental health during the pandemic. Furthermore, differences in depressive symptomatology were observed among different demographic groups and types of coagulation disorder. However, no significant differences were found in the total BDI score between groups, suggesting uniformity in depression levels globally. This study highlights the importance of considering both medical and emotional aspects in the comprehensive care of patients with coagulation disorders. The findings provide valuable information for designing interventions and treatment strategies tailored to the specific needs of each subgroup of patients, with the aim of improving the mental health of this vulnerable population during the COVID-19 pandemic.

Zitieren

APA

Castillo, D. F. E., Zapata, H. A. R., Estrella, A. D. J. L., Lizama, E. V., Olán, L. I., Salomón, M. R., & Ventura, M. A. R. (2025). Sintomatología depresiva en pacientes con trastornos de coagulación durante COVID 19: Análisis sociodemográfico y comparativo. Ciencia y Humanismo en la Salud. https://doi.org/10.32776/8aqa7r08

Vancouver

Castillo DFE, Zapata HAR, Estrella ADJL, Lizama EV, Olán LI, Salomón MR, et al. Sintomatología depresiva en pacientes con trastornos de coagulación durante COVID 19: Análisis sociodemográfico y comparativo. Ciencia y Humanismo en la Salud. 2025. doi:10.32776/8aqa7r08

BibTeX
@article{Castillo2025,
  author = {Castillo, Damaris Francis Estrella and Zapata, Hector Armando Rubio and Estrella, Armando de Jesús López and Lizama, Elma Vega and Olán, Laura Isidro and Salomón, Marco Ramírez and Ventura, Marco Antonio Rueda},
  title = {Sintomatología depresiva en pacientes con trastornos de coagulación durante COVID 19: Análisis sociodemográfico y comparativo},
  journal = {Ciencia y Humanismo en la Salud},
  year = {2025},
  doi = {10.32776/8aqa7r08}
}
Kostenlos starten →